These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

870 related items for PubMed ID: 27350555

  • 1. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J.
    Diagn Pathol; 2016 Jun 27; 11(1):55. PubMed ID: 27350555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
    Routhier CA, Mochel MC, Lynch K, Dias-Santagata D, Louis DN, Hoang MP.
    Hum Pathol; 2013 Nov 27; 44(11):2563-70. PubMed ID: 24071017
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
    Estrella JS, Tetzlaff MT, Bassett RL, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR.
    Mol Cancer Ther; 2015 Dec 27; 14(12):2887-95. PubMed ID: 26438153
    [Abstract] [Full Text] [Related]

  • 11. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL.
    J Surg Oncol; 2015 Mar 27; 111(3):359-64. PubMed ID: 25346165
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Epithelioid glioblastoma with BRAF V600E mutation: a clinicopathological and molecular study].
    Zheng LM, Gong J, Zou Y, Zhang MN, Yu TP, Hou J, Zhou Q, Chen N.
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar 08; 50(3):229-235. PubMed ID: 33677887
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors.
    Breton Q, Plouhinec H, Prunier-Mirebeau D, Boisselier B, Michalak S, Menei P, Rousseau A.
    Brain Behav; 2017 Mar 08; 7(3):e00641. PubMed ID: 28293477
    [Abstract] [Full Text] [Related]

  • 19. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
    Matsumura N, Nakajima N, Yamazaki T, Nagano T, Kagoshima K, Nobusawa S, Ikota H, Yokoo H.
    Neuropathology; 2017 Feb 08; 37(1):58-63. PubMed ID: 27302309
    [Abstract] [Full Text] [Related]

  • 20. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
    Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A.
    Acta Neuropathol; 2011 Jul 08; 122(1):11-9. PubMed ID: 21638088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.